BiovaxID

· Biovest International

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BiovaxID, covering 2012-02-03 to 2012-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma [Phase 3]